This video series is designed to teach bench researchers how scientists in scientific enterprises structure business deals to achieve strategic goals. Content covers an overview of the business development process and includes identifying gaps, deal types and structure, and defining success. Concepts will be reinforced using practical examples from academic and industry settings.
Anatol Kreitzer, PhD is an Associate Investigator at the Gladstone Institute of Neurological Disease and Associate Professor of Physiology and Neurology at UCSF. Dr. Kreitzer’s research focuses on the disordered physiological processes associated with Parkinson’s disease. He is an expert in the emerging field of optogenetics—the application of genetic and optical techniques to remotely control… Continue Reading
Daniel Dornbusch has served in multiple management roles at pharmaceutical, biotechnology, diagnostics, and strategy consulting companies including Novartis, Genentech, Amerisource Bergen and Genzyme. Daniel has spent almost 20 years in the healthcare industry in various roles including business development, sales, marketing, corporate development, and commercial management. Daniel is a founder of KidsDOC, a telemedicine company,… Continue Reading
Asha S. Collins leads the US Clinical Trial Sourcing business at McKesson Corporation, one of the largest healthcare organizations in North America. In this position, she leads a team that strategically sources commercial products for research and clinical trial studies. Prior to McKesson, Asha focused on leading biopharmaceutical companies through strategic change as a management… Continue Reading